German Tech Hardware Stock News

As the European markets navigate a complex landscape of steady interest rates and mixed performances across major indices, investors are keenly observing opportunities that may arise from these fluctuations. In this context, identifying promising stocks often involves looking beyond immediate market trends to uncover companies with strong fundamentals and potential for growth amidst economic shifts.

Key Insights Using the 2 Stage Free Cash Flow to Equity, PNE fair value estimate is €16.86 PNE's €10.32 share price...

With a price-to-earnings (or "P/E") ratio of 2.3x TMM Real Estate Development Plc ( FRA:TR61 ) may be sending very...

Evonik Industries (XTRA:EVK) posted a mixed set of results for investors, as EPS was pressured by a one-off €242 million loss over the past 12 months, dragging net profit margins down to 0.7% from 1.5% last year. Earnings have declined at an average annual rate of 32.4% over the past five years, but projections are turning heads. The company now expects earnings to grow 35.7% annually, which is significantly higher than the German market's 16.9% yearly growth forecast. While EVK's revenue...

As European markets experience mixed performances, with the STOXX Europe 600 Index recently pulling back slightly after reaching new highs, investors are closely watching for signals from the European Central Bank amid stable inflation rates. In this environment, dividend stocks can offer a measure of stability and income potential, making them an attractive option for those looking to navigate uncertain market conditions.

While Wacker Neuson SE ( ETR:WAC ) might not have the largest market cap around , it saw significant share price...

Wondering if Fresenius SE KGaA is truly a bargain or just riding the wave? You're not alone. The stock's value is a hot topic for investors eyeing healthcare giants. After soaring 43.5% year-to-date, with a 41.7% gain over the last year, it's clear things are moving. However, the past week has seen a 5.0% pullback, adding a dose of short-term volatility to the mix. Recent headlines have revolved around Fresenius advancing its strategic transformation, including portfolio streamlining and a...

Elmos Semiconductor (XTRA:ELG) posted earnings growth of 21.5% over the last year, outpacing its current net profit margin of 22.2% compared to 17.2% in the previous period. Shares recently traded at €90.4, above an estimated fair value of €78.5 according to a discounted cash flow model. The stock’s Price-to-Earnings ratio of 12.5x stands well below peer and industry averages. With revenue expected to grow at 9.1% annually and margins expanding, the latest results underscore a compelling mix...

Nemetschek (XTRA:NEM) delivered earnings growth of 19.5% over the last year, handily outpacing its 5-year average of 11.5% per year. Net profit margin stands at 17.6%, a touch below last year’s 18.5%, with earnings expected to continue rising faster than the German market at 18.4% per year ahead. With solid growth forecasts and no flagged risks, investors will be weighing the strong growth outlook, high-quality earnings, and fair value discount against a premium Price-To-Earnings Ratio that...

Fresenius Medical Care (XTRA:FME) expects earnings to grow at 17.43% per year, backed by revenue projected to expand 4.1% annually. The company’s net profit margin has edged up to 3.7% from 3.4% a year ago. Earnings have also reversed a five-year decline of 17% per year to grow 9% over the past year. With shares trading at €41.76 and a price-to-earnings ratio of 16.8x, which is well below both peers and the European healthcare sector average, these numbers signal renewed momentum and...

Nordex (XTRA:NDX1) continued its remarkable earnings improvement, with profitability rising at an annual rate of 20.3% over the past five years and a dramatic jump of 384.7% in the latest year. Net profit margins climbed to 1.5%, up from 0.3% a year earlier. Revenue is forecast to grow 7.1% annually, topping the 6.1% pace of the wider German market. With earnings projected to increase 33.7% per year going forward, the company stands out for both ongoing growth and a strong margin turnaround...

Innoscripta (XTRA:1INN) continues its strong run with net profit margins climbing to 40.4%, up from 36.6% last year, and a substantial 82.2% earnings growth over the past year. This performance is well ahead of its already impressive five-year average of 44% per year. Looking forward, analysts expect both revenue and earnings to rise at rapid clips of 24.7% and 27.2% per year, respectively, outpacing the broader German market. Investors will likely view this momentum, paired with a share...

Schaeffler (XTRA:SHA0) currently faces rising losses, with net losses having grown 28.8% per year over the last five years and no reported improvement in net profit margin over the past twelve months. However, the company’s revenue is forecast to grow 3.6% per year, which trails the German market’s pace of 6.1%. Expectations are for a striking turnaround, with earnings projected to grow 135.4% annually and a return to profitability within three years. As investors weigh risks around financial...

Wondering if Siemens Healthineers is trading at a great price or if you are chasing the story too late? You are not alone. Let's dig into what the current market is saying. The stock has nudged up 0.8% over the past week and managed a steady 3.5% gain for the year, signaling renewed interest and possibly shifting risk perceptions. Recent news around advancements in medical imaging technology and key partnerships have been grabbing headlines, giving investors more to weigh as the company...

The recent buzz around Circus (XTRA:CA1) comes after its autonomous CA-1 cooking robot made a highly anticipated premiere inside a REWE supermarket. This partnership introduces automated live meal preparation directly in-store, which is a global first. See our latest analysis for Circus. The excitement generated by Circus’s global-first launch at REWE comes on the heels of several rapid-fire developments, including the rollout of a six-month pilot program, new partnerships in Ukraine, and a...

learnd SE ( FRA:LRND ) shareholders are no doubt pleased to see that the share price has bounced 31% in the last month...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Key Insights Insiders appear to have a vested interest in KWS SAAT SE KGaA's growth, as seen by their sizeable...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...

Readers hoping to buy CeoTronics AG ( FRA:CEK ) for its dividend will need to make their move shortly, as the stock is...

TUI AG ( ETR:TUI1 ), is not the largest company out there, but it saw significant share price movement during recent...

Wondering if Evonik Industries might be a bargain or a value trap? You're not alone. Plenty of investors are watching for signs the stock is undervalued. Despite some ups and downs, the share price has dipped 3.3% this week and is down 14.4% so far this year, signaling shifting market sentiment and possibly fresh opportunities. Market chatter has picked up around Evonik’s portfolio restructuring and sustainability initiatives, both of which have caught the attention of analysts and industry...

Deutsche Lufthansa AG reported its third quarter and nine-month 2025 earnings results last week, revealing quarterly net income of €966 million and nine-month net income of €1.09 billion. While the quarter's profit was slightly lower year-over-year, the company's earnings for the nine-month period showed a substantial improvement from the previous year. We'll explore how Lufthansa's higher nine-month net income shapes the company's investment narrative heading into year-end 2025. Trump has...